Sign in
Active, not recruitingPhase 3

Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain

Key facts

Who runs it
Saol Therapeutics Inc
Where
Altoona, Bellaire, Charleston, Charlotte, Coral Gables, Corpus Christi, Edmond, Eugene, Greenville, Greenwood Village, Orlando, Richmond, Rochester, Roseville, Salt Lake City, San Diego, Sewickley, The Villages, Tyler, Washington D.C., Winston-Salem, and Winter Park, United StatesSee the 22 sites
Trial code
Status
Active, not recruiting
Phase
Phase 3
People taking part
150 people, planned
Started
7 Nov 2025
Expected to end
28 Feb 2027
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • SL1002
  • Normal Saline
Record updated
20 October 2026

Who can take part

Age
40 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 22 criteriaShow less

Who can take part

  • Male or female patients ≥ 40 years of age
  • Body Mass Index (BMI) limits
  • Chronic knee pain resulting from osteoarthritis
  • Kellgren-Lawrence Grade 2 (mild) or Grade 3 (moderate)
  • Baseline KOOS pain
  • Patients taking baseline analgesics
  • Diagnostic nerve block response
  • Compliance with identified study requirements

Who cannot take part

  • Identifiable baseline medications
  • Identified alcohol or drug abuse history
  • Identified underlying physiologic or psychosocial conditions
  • Moderate to severe hepatic impairment
  • Moderate to severe renal impairment
  • Known allergies or hypersensitivity to identified agents
  • Identified underlying abnormal laboratory results
  • Non-OA inflammatory arthritis
  • Confounding elements
  • Lower limb amputation
  • Specified alternate historic treatments
  • Patient Health Questionnaire
  • Protocol compliance requirements
  • Identified underlying physical exam findings: ECG abnormalities or vital sign abnormalities during study screening per investigator assessment

Where in United States

  • University Orthopedics CenterAltoona, United States
  • Legent Orthopedic and Spine HospitalBellaire, United States
  • Medical University of South Carolina (MUSC)Charleston, United States
  • Queen City Clinical Research, PLLCCharlotte, United States
  • Prime Medical ResearchCoral Gables, United States
  • Institute of Precision Pain MedicineCorpus Christi, United States
  • Comprehensive Specialty CareEdmond, United States
  • Pacific Sports and SpineEugene, United States
  • PCPMG Clinical Research Unit, LLCGreenville, United States
  • DBPS Research, LLCGreenwood Village, United States
  • Conquest Research, LLCOrlando, United States
  • Virginia iSpine Physicians, PCRichmond, United States
  • Mayo ClinicRochester, United States
  • Sutter Neurology and Pain ManagementRoseville, United States
  • University of Utah Orthopedic CenterSalt Lake City, United States
  • Innovative Pain Treatment SolutionsSan Diego, United States
  • Pain Diagnostics & Interventional Care LLCSewickley, United States
  • Interventional Pain InstituteThe Villages, United States
  • International Spine, Pain & Performance Center (IPP)Tyler, United States
  • International Spine, Pain & Performance CenterWashington D.C., United States
  • The Center for Clinical ResearchWinston-Salem, United States
  • Conquest Research, LLCWinter Park, United States

About the trial

What the trial wants to find out

A Randomized, Double-Blind, Placebo-Controlled, Single Dose Study to Assess the Safety and Efficacy of SL1002 for the Treatment of Knee Pain in Patients with Osteoarthritis of the Knee.

The 2 groups in the trial

  • SL1002Treatment being tested
  • PlaceboPlacebo, for comparison

    Normal saline

    Treatment: Normal Saline

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Randomized, Double-Blind, Placebo-Controlled, Single Dose Study to Assess the Safety and Efficacy of SL1002 Injectable for the Treatment of Knee Pain in Patients With Osteoarthritis of the Knee
Record updated
20 October 2026